Investigation of The Antitumor Mechanism of Cyproheptadine and The Role and Function of ANGPTL4 in Bladder Urothelial Carcinoma
博士 === 國立中正大學 === 分子生物研究所 === 104 === Cyproheptadine (CPH), a first-generation antihistamine, has recently been reported to function as a novel therapeutic agent in cancers, but never been explored in urothelial carcinoma (UC). In our study, we determined the effect of CPH on the growth of human bla...
Main Authors: | Hsiao-Yen Hsieh, 謝小燕 |
---|---|
Other Authors: | Michael Wing-Yan Chan |
Format: | Others |
Language: | en_US |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/8m73uc |
Similar Items
-
The role of cyproheptadine as an epigenetic modifier in restoring innate immune response in urothelial carcinoma
by: YEH, CHIH-CHIEH, et al.
Published: (2018) -
Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
by: Yeong-Chin Jou, et al.
Published: (2021-04-01) -
Grading of urothelial carcinoma of the bladder
by: M. V. Kovylina, et al.
Published: (2017-06-01) -
Plasmacytoid urothelial carcinoma of the bladder
by: Meihua Qin, et al.
Published: (2014-01-01) -
Chromium in urothelial carcinoma of the bladder
by: Tomasz Golabek, et al.
Published: (2017-12-01)